Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation

Osteoarthritis and Cartilage

Volumn 15, Issue 6, 2007, Pages 646-655

  Derfoul, A ^a   Miyoshi, A D ^a   Freeman, D E ^a   Tuan, R S ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

Cartilage; Chondrocytes; Glucosamine; Matrix metalloproteinase 13; Mesenchymal stem cells; Osteoarthritis

Indexed keywords

AGGRECAN; COLLAGEN TYPE 2; COLLAGENASE 3; GAG PROTEIN; GLUCOSAMINE; INTERLEUKIN 1BETA; MATRIX PROTEIN;

ARTICLE; CARTILAGE CELL; CARTILAGE MATRIX; CELL GROWTH; CELL STIMULATION; CHONDROGENESIS; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; OSTEOARTHRITIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; GENE EXPRESSION REGULATION; GLUCOSAMINE; HUMANS; MATRIX METALLOPROTEINASE 13; MESENCHYMAL STEM CELLS; OSTEOARTHRITIS;

EID: 34249007891     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2007.01.014     Document Type: Article

References (37)

1. Dieppe P. Therapeutic targets in osteoarthritis. J Rheumatol Suppl 43 (1995) 136-139
2. Inerot S., Heinegard D., Audell L., and Olsson S.E. Articular-cartilage proteoglycans in aging and osteoarthritis. Biochem J 169 (1978) 143-156
3. Pelletier J.P., Cloutier J.M., and Martel-Pelletier J. In vitro effects of NSAIDs and corticosteroids on the synthesis and secretion of interleukin 1 by human osteoarthritic synovial membranes. Agents Actions Suppl 39 (1993) 181-193
4. Dinarello C.A. Interleukin-1. Dig Dis Sci 33 (1988) 25S-35S
5. Benton H.P., and Tyler J.A. Inhibition of cartilage proteoglycan synthesis by interleukin I. Biochem Biophys Res Commun 154 (1988) 421-428
6. Tyler J.A., and Benton H.P. Synthesis of type II collagen is decreased in cartilage cultured with interleukin 1 while the rate of intracellular degradation remains unchanged. Coll Relat Res 8 (1988) 393-405
7. Shikhman A.R., Brinson D.C., and Lotz M. Profile of glycosaminoglycan-degrading glycosidases and glycoside sulfatases secreted by human articular chondrocytes in homeostasis and inflammation. Arthritis Rheum 43 (2000) 1307-1314
8. Vincenti M.P., Coon C.I., Lee O., and Brinckerhoff C.E. Regulation of collagenase gene expression by IL-1 beta requires transcriptional and post-transcriptional mechanisms. Nucleic Acids Res 22 (1994) 4818-4827
9. Setnikar I., Giachetti C., and Zanolo G. Absorption, distribution and excretion of radioactivity after a single intravenous or oral administration of [14C] glucosamine to the rat. Pharmatherapeutica 3 (1984) 538-550
10. Kleine T.O., and Baumann H.J. In-vivo biosynthesis of acid glycosaminoglycans with radiosulfate and [3H]glucosamine in single joints from rats of different age. Z Gerontol 23 (1990) 123-125
11. Richy F., Bruyere O., Ethgen O., Cucherat M., Henrotin Y., and Reginster J.Y. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med 163 (2003) 1514-1522
12. McAlindon T.E., LaValley M.P., Gulin J.P., and Felson D.T. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 283 (2000) 1469-1475
13. Leeb B.F., Schweitzer H., Montag K., and Smolen J.S. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol 27 (2000) 205-211
14. Bruyere O., Pavelka K., Rovati L.C., Deroisy R., Olejarova M., Gatterova J., et al. Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies. Menopause 11 (2004) 138-143
15. Reginster J.Y., Deroisy R., Rovati L.C., Lee R.L., Lejeune E., Bruyere O., et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 357 (2001) 251-256
16. Clegg D.O., Reda D.J., Harris C.L., Klein M.A., O'Dell J.R., Hooper M.M., et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 354 (2006) 795-808
17. Shikhman A.R., Kuhn K., Alaaeddine N., and Lotz M. N-acetylglucosamine prevents IL-1 beta-mediated activation of human chondrocytes. J Immunol 166 (2001) 5155-5160
18. Dodge G.R., and Jimenez S.A. Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes. Osteoarthritis Cartilage 11 (2003) 424-432
19. Chan P.S., Caron J.P., Rosa G.J., and Orth M.W. Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E(2) in articular cartilage explants. Osteoarthritis Cartilage 13 (2005) 387-394
20. Tallheden T., Dennis J.E., Lennon D.P., Sjogren-Jansson E., Caplan A.I., and Lindahl A. Phenotypic plasticity of human articular chondrocytes. J Bone Joint Surg Am 85-A Suppl 2 (2003) 93-100
21. Alsalameh S., Amin R., Gemba T., and Lotz M. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum 50 (2004) 1522-1532
22. Noth U., Osyczka A.M., Tuli R., Hickok N.J., Danielson K.G., and Tuan R.S. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 20 (2002) 1060-1069
23. Osyczka A.M., Noth U., O'Connor J., Caterson E.J., Yoon K., Danielson K.G., et al. Multilineage differentiation of adult human bone marrow progenitor cells transduced with human papilloma virus type 16 E6/E7 genes. Calcif Tissue Int 71 (2002) 447-458
24. Osyczka A.M., Noth U., Danielson K.G., and Tuan R.S. Different osteochondral potential of clonal cell lines derived from adult human trabecular bone. Ann N Y Acad Sci 961 (2002) 73-77
25. Reginster J.Y. Chondromodulation in 2003: dream or reality?. Rev Med Suisse Romande 124 (2004) 85-87
26. Verbruggen G. Chondroprotective drugs in degenerative joint diseases. Rheumatology (Oxford) (2005)
27. Song L., Young N.J., Webb N.E., and Tuan R.S. Origin and characterization of multipotential mesenchymal stem cells derived from adult human trabecular bone. Stem Cells Dev 14 (2005) 712-721
28. Tuli R., Tuli S., Nandi S., Wang M.L., Alexander P.G., Haleem-Smith H., et al. Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells 21 (2003) 681-693
29. Derfoul A., Perkins G.L., Hall D.J., and Tuan R.S. Glucocorticoids promote chondrogenic differentiation of adult human mesenchymal stem cells by enhancing expression of cartilage extracellular matrix genes. Stem Cells 24 (2006) 1487-1495
30. Persiani S., Roda E., Rovati L.C., Locatelli M., Giacovelli G., and Roda A. Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man. Osteoarthritis Cartilage 13 (2005) 1041-1049
31. de Mattei M., Pellati A., Pasello M., de Terlizzi F., Massari L., Gemmati D., et al. High doses of glucosamine-HCl have detrimental effects on bovine articular cartilage explants cultured in vitro. Osteoarthritis Cartilage 10 (2002) 816-825
32. Largo R., Alvarez-Soria M.A., Diez-Ortego I., Calvo E., Sanchez-Pernaute O., Egido J., et al. Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 11 (2003) 290-298
33. Shikhman A.R., Amiel D., D'Lima D., Hwang S.B., Hu C., Xu A., et al. Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis. Ann Rheum Dis 64 (2005) 89-94
34. Oegema Jr. T.R., Deloria L.B., Sandy J.D., and Hart D.A. Effect of oral glucosamine on cartilage and meniscus in normal and chymopapain-injected knees of young rabbits. Arthritis Rheum 46 (2002) 2495-2503
35. Ilic M.Z., Martinac B., and Handley C.J. Effects of long-term exposure to glucosamine and mannosamine on aggrecan degradation in articular cartilage. Osteoarthritis Cartilage 11 (2003) 613-622
36. Lippiello L. Glucosamine and chondroitin sulfate: biological response modifiers of chondrocytes under simulated conditions of joint stress. Osteoarthritis Cartilage 11 (2003) 335-342
37. Bassleer C, Rovati L, Franchimont P. Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human. Osteoarthritis Cartilage 1998;6:427--34.